Ex Parte MeskensDownload PDFPatent Trial and Appeal BoardSep 20, 201712391029 (P.T.A.B. Sep. 20, 2017) Copy Citation United States Patent and Trademark Office UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O.Box 1450 Alexandria, Virginia 22313-1450 www.uspto.gov APPLICATION NO. FILING DATE FIRST NAMED INVENTOR ATTORNEY DOCKET NO. CONFIRMATION NO. 12/391,029 02/23/2009 Werner Meskens 3065.0042C 6271 110239 7590 09/22/2017 Edell Shapiro & Finnan LLC 9801 Washingtonian Blvd., Suite 750 Gaithersburg, MD 20878 EXAMINER LEVICKY, WILLIAM J ART UNIT PAPER NUMBER 3762 NOTIFICATION DATE DELIVERY MODE 09/22/2017 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address(es): epatent@usiplaw.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte WERNER MESKENS1 Appeal 2016-003617 Application 12/391,029 Technology Center 3700 Before ERIC B. GRIMES, RICHARD J. SMITH, and TIMOTHY G. MAJORS, Administrative Patent Judges. GRIMES, Administrative Patent Judge. DECISION ON APPEAL This is an appeal under 35U.S.C. § 134 involving claims to a cochlear implant, which have been rejected as obvious. We have jurisdiction under 35 U.S.C. § 6(b). We reverse. STATEMENT OF THE CASE “Cochlear implants are to a specific type of hearing prostheses that deliver electrical stimulation to the cochlea of a recipient.” (Spec. 1 5.) The Specification discloses a cochlear implant in which power and data are 1 Appellant identifies the Real Party in Interest as Cochlear Limited. (Appeal Br. 2.) Appeal 2016-003617 Application 12/391,029 transmitted transcutaneously over a single frequency channel to an implanted component. {Id. 1 6.) To transfer the power and data, the transcutaneous communication link implements a time interleaving scheme having successive time frames that are each divided into two or more time slots. One or more of the time slots in each frame is allocated to the data transmitter unit, and one or more of the time slots in each frame is allocated to the power transmitter unit. The data and power are transmitted by the respective transmitter units to the receiver unit during the time slots allocated thereto. {Id. 129.) Claims 1, 2, 4, 6—16, 18, 19, 21, 22, 24, and 26—37 are on appeal. Claim 1 is illustrative and reads as follows (emphasis added): 1. A cochlear implant comprising: an implantable component having an electrode assembly insertable in a recipient’s cochlea and a stimulator/receiver unit configured to deliver stimulation signals to the recipient's cochlea via the electrode assembly; an external charging module having a power transmitter unit; and a data module that is physically separate from the external charging module, wherein the data module comprises a data transmitter unit; wherein the data transmitter unit and the power transmitter unit are each configured to establish a transcutaneous communication link with the implantable component over which data and power, respectively, are transmitted on a single shared frequency channel, and wherein the data transmitter unit and the power transmitter unit collectively implement a time interleaving scheme comprising successive frames each divided into at least two time slots in order to share the single shared frequency channel; wherein one or more of the time slots in each frame is allocated to the data transmitter unit and one or more of the time slots in each frame is allocated to the power transmitter unit, wherein data and power are transmitted by the transmitter units during different time slots; 2 Appeal 2016-003617 Application 12/391,029 wherein the one or more time slots in each frame are dynamically allocated to the power transmitter unit and the data transmitter unit in real time based on a state of the cochlear implant; and wherein the data module and external charging module are configured to directly exchange data with one another to synchronize the transmission of power and data on the single shared frequency channel. Claims 15 and 21, the only other independent claims, both include substantially the same limitation italicized above in claim 1. The claims stand rejected as follows: Claims 1, 2, 6, 7, 10, 13—16, 18, 21, 22, 26, 27, 30, and 33—37 under 35 U.S.C. § 103(a) as obvious based on Stokes2 and Wahlstrand3 (Final Action4 4); Claims 4, 19, and 24 under 35 U.S.C. § 103(a) as obvious based on Stokes, Wahlstrand, and Patrias5 (Final Action 9); Claims 8, 9, 28, and 29 under 35 U.S.C. § 103(a) as obvious based on Stokes, Wahlstrand, and Faltys6 (Final Action 9-10); and Claims 11, 12, 31, and 32 under 35 U.S.C. § 103(a) as obvious based on Stokes, Wahlstrand, and Griffith7 (Final Action 11). DISCUSSION The Examiner has rejected all of the claims on appeal as obvious based on Stokes and Wahlstrand, by themselves or combined with one of 2 Stokes et al., US 5,814,089, issued September 29, 1989. 3 Wahlstrand et al., US 2005/0004619, published January 6, 2005. 4 Office Action mailed Apr. 23, 2015. 5 Patrias, US 7,162,307 B2, issued January 9, 2007. 6 Faltys et al., US 6,308,101 Bl, issued October 23, 2001. 7 Griffith, US 2006/0190059 Al, published August 24, 2006. 3 Appeal 2016-003617 Application 12/391,029 Patrias, Faltys, or Griffith. The same issue is dispositive for all of the rejections. The Examiner finds that Stokes discloses most of the limitations of claim 1, including the recited time interleaving scheme. (Final Action 5—6.) The Examiner finds that Wahlstrand discloses a data module that is physically separate from a charging module, where the two modules are configured to exchange data with each other. (Id. at 6.) The Examiner concludes that it would have been obvious to modify Stokes’ device to have separate data and charging modules to “provid[e] improved processing power and/or improved safety and control over the controller.” (Id.) Appellant argues that “the cited references, taken alone or in combination, fail to teach or suggest all elements of claim 1,” including the specific time interleaving scheme recited in claim 1. (Appeal Br. 11, 15.) Appellant argues that no where [sic] does Stokes state that there is any type of framing structure for transmission of power and/or data. Additionally, no where [sic] does Stokes state that power transmissions occur in allocated time slots. In fact, Stokes states that “power is transmitted between ‘events’ such as stimulation, sensing data transmission from a remote unit, etc.” Stokes at col. 5, Ins 49- 51. In other words, in Stokes, power is received at irregular times (i.e., unpredictable power slot timing structure). (Id.) In response to this argument, the Examiner reasons that “the frame could be day(s), month(s) or year(s), since the claim does not establish what is meant by a frame. . . . Therefore, it is assumed that the frame ends after every indication that charging has ended and after the frame ends a new frame begins until the next indication that the charge has ended.” (Ans. 4.) 4 Appeal 2016-003617 Application 12/391,029 We agree with Appellant that the Examiner has not persuasively shown that Stokes discloses the time interleaving scheme recited in claim 1, when the claim language is given its broadest reasonable interpretation in light of the Specification. [T]he PTO applies to the verbiage of the proposed claims the broadest reasonable meaning of the words in their ordinary usage as they would be understood by one of ordinary skill in the art, taking into account whatever enlightenment by way of definitions or otherwise that may be afforded by the written description contained in the applicant’s specification. In re Morris, 127 F.3d 1048, 1054 (Fed. Cir. 1997). In relevant part, claim 1 recites “a time interleaving scheme comprising successive frames each divided into at least two time slots in order to share the single shared frequency channel; wherein one or more of the time slots in each frame is allocated to the data transmitter unit and one or more of the time slots in each frame is allocated to the power transmitter unit.” (Claim 1.) The Specification states that “[a]s used herein, a time interleaving scheme is a channel access protocol in which two or more devices share a common or overlapping frequency channel band. The scheme includes successive time frames which are each divided into two or more time slots. The two or more devices are each allocated time slots within each frame for transmission of data or power.” (Spec. 1 59.) The Specification illustrates examples of time interleaving schemes in Figures 4A through 4E. {Id. | 60.) In all of the exemplary schemes, each time frame has a fixed time length and is divided into two or more time slots that are allocated for transmission of either data or power. {Id. Tflf 60, 68.) 5 Appeal 2016-003617 Application 12/391,029 Those allocations can be made dynamically “based on the power demands of the implantable component, or the need to transfer a large amount of data.” {Id. 65, 75.) However, the claim language, read in light of the Specification, nonetheless requires the time interleaving scheme to be based on successive time frames, each of which has a fixed time length, that are divided into time slots that can be allocated for transfer of either power or data, “wherein one or more of the time slots in each frame is allocated to the data transmitter unit and one or more of the time slots in each frame is allocated to the power transmitter unit.” (Claim 1.) Stokes discloses “an implantable leadless system for stimulating plural sites in a patient and/or collecting data from such sites for external transmission. . . . [T]he term Teadless’ refers to the absence of a lead interconnecting the plural sites.” (Stokes 2:24—28.) Stokes’ system includes an “implantable controller unit. . . which provides transmission of power and data to each of remote units.” {Id. at 3:30-32.) The implantable controller unit includes modulator portion 36, and “[t]he output of the modulator/power converter circuit 36 is coupled to transmitter 37, which transmits a high frequency signal containing a power component and a data component.” {Id. at 4:9-10, 22—28.) Stokes’ Figure 2B is reproduced below: 76 Figure 2B shows “a time diagram illustrating the nature of data encoded onto a high frequency carrier, which is transmitted from transmitter 6 Appeal 2016-003617 Application 12/391,029 37 to one or more external implanted devices.” (Id. at 5:8—11.) Specifically, “at 75 there is shown a constant asynchronous ‘trickle charge’ signal, which is a power carrying signal.” (Id. at 5:32—34.) “[Tjhere may optionally be a reset code as illustrated at 76, to communicate to the remote device that the trickle charge has been completed.” (Id. at 5:36—38.) Another optional feature is identification code 78, which “may be used to direct control data . . . to selected one or more remote devices.” (Id. at 5:39-44.) “Following this, the information or data signal is delivered, as illustrated at 80. This data . . . carries control data to instruct the remote stimulator or device as to its operation.” (Id. at 5:44-47.) Stokes states that “[t]he power is transmitted between ‘events’ such as stimulation, sensing data transmission from a remote unit, etc.” (Id. at 5:50— 52.) Stokes also states that its Figures 4A and 4B “illustrat[e] the method of this invention for providing power to one or more of the remote units ‘on request,’ i.e., when and as the remote unit signals that it needs power.” (Id. at 6:67 to 7:3.) Thus, although Stokes discloses providing power and data over a single frequency channel, it does not disclose a time interleaving scheme as required by claim 1 because it does not disclose successive time frames having a fixed time length, that are divided into time slots allocated for transfer of power or data, “wherein one or more of the time slots in each frame is allocated to the data transmitter unit and one or more of the time slots in each frame is allocated to the power transmitter unit.” As noted above, independent claims 15 and 21 also include substantially the same limitation, and the rejection of these claims, as well as dependent claims 2, 7 Appeal 2016-003617 Application 12/391,029 6, 7, 10, 13, 14, 16, 18, 22, 26, 27, 30, and 33—37, suffers from the same deficiency. With regard to the rejections based on Stokes and Wahlstrand, combined with Patrias, Faltys, or Griffith, the Examiner finds that the additional references disclose limitations of dependent claims but does not point to anything in them that remedies the deficiency discussed above. (Final Action 9—12.) We therefore reverse those rejections for the reasons discussed above. SUMMARY We reverse all of the rejections on appeal. REVERSED 8 Copy with citationCopy as parenthetical citation